Join to view full profile
7875 W Commercial BlvdTamarac, FL 33351
Phone+1 954-726-0099
Fax+1 954-726-0047
Dr. Haffizulla is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jason Haffizulla is an internal medicine specialist based in Tamarac, FL. He completed his medical degree at the University of Miami Leonard M. Miller School of Medicine in 2000 and his internal medicine residency at the Cleveland Clinic Foundation/Florida Weston in 2003. Since then, he has been a partner at the Medical Associates of Tamarac. Dr. Haffizulla has published research articles, including a study on a SARS-CoV-2 vaccine in NPJ Vaccines and a trial on influenza treatment in The Lancet Infectious Diseases. He has also been involved in a clinical trial assessing the efficacy of Gemcabene in patients with severe hypertriglyceridemia.
Education & Training
Cleveland Clinic Foundation/Florida WestonResidency, Internal Medicine, 2000 - 2003
University of Miami Leonard M. Miller School of MedicineClass of 2000
Certifications & Licensure
FL State Medical License 2002 - 2027
American Board of Internal Medicine Internal Medicine
Clinical Trials
Publications & Presentations
PubMed
- 27 citationsSafety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without Comorbidities.Nathalie Charland, Philipe Gobeil, Stéphane Pillet, Iohann Boulay, Annie Séguin
NPJ Vaccines. 2022-11-09 - 186 citationsEffect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trialJason Haffizulla, Aaron Hartman, Melanie Hoppers, Harvey Resnick, Steve Samudrala
The Lancet. Infectious Diseases. 2014-07-01
Press Mentions
Local Study Expands Benefits of Plant Based Smoking Cessation PillJuly 28th, 2022- Research Underway into Adult Vaccine for Respiratory Syncytial VirusOctober 5th, 2021
- Leading with Empathy and Compassion Drives ChangeMay 13th, 2021
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
